For patients with a hip fracture who are at moderate to high risk of a cardiovascular event, continue ASA around the time of surgery.
Neuraxial blockade is possible in patients receiving ASA.
The fact that a patient was already taking ASA is not a reason to delay surgery. There is no specific antidote. In case of intraoperative bleeding, administer platelet transfusion.
<%= buttons %>